54 reports

Moreover, the rise in the geriatric population coupled with prevalence of diseases is one of the major factors driving the demand for cell line development for biotherapeutics.

  • Biotherapeutic
  • Cell Therapy
  • United States
  • World
  • Demand

To realize the full therapeutic and commercial potential of biologicals, drug developers and technologists are applying a number of innovative solutions which are aimed at addressing the limitations of biological drugs one by one.

  • Biological Therapy
  • Biotherapeutic

Protalix BioTherapeutics, Inc.

  • Biological Therapy
  • Biotherapeutic
  • Israel
  • Market Competition

Oxygen Biotherapeutics, Inc.

  • Biological Therapy
  • Biotherapeutic
  • United States
  • Market Competition
  • Iovance Biotherapeutics Inc, History
  • Iovance Biotherapeutics Inc, Subsidiaries

Iovance Biotherapeutics Inc (IOVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities...

  • Biotherapeutic
  • United States
  • World
  • Company Financials
  • BioTherapeutics Inc.
  • PROTALIX BIOTHERAPEUTICS INC - STRENGTHS
  • PROTALIX BIOTHERAPEUTICS INC, HISTORY

Summary Protalix BioTherapeutics Inc (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins. The company’s marketed product, Taliglucerase (taliglucerase alfa) is an enzyme replacement therapy (ERT) for the long-term treatment of adult patients with a confirmed diagnosis...

  • Biotherapeutic
  • Brazil
  • United States
  • Company Financials
  • Protalix BioTherapeutics, Inc.
  • PROTALIX BIOTHERAPEUTICS INC, SUBSIDIARIES
  • PROTALIX BIOTHERAPEUTICS INC, KEY EMPLOYEES

Summary Protalix BioTherapeutics Inc (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins. The company’s marketed product, Taliglucerase (taliglucerase alfa) is an enzyme replacement therapy (ERT) for the long-term treatment of adult patients with a confirmed diagnosis...

  • Biotherapeutic
  • Brazil
  • United States
  • Company
  • Protalix BioTherapeutics, Inc.
  • AEGLEA BIOTHERAPEUTICS INC, KEY COMPETITORS
  • AEGLEA BIOTHERAPEUTICS INC - KEY EMPLOYEES

Summary Aeglea BioTherapeutics Inc (Aeglea BioTherapeutics), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment of cancer and rare genetic diseases.The company’s product pipeline comprises AEB1102, AEB3103, AEB2109, and AEB4104. It...

  • Biotherapeutic
  • Pharmaceutical
  • United States
  • Company
  • Aeglea BioTherapeutics
  • Gene Biotherapeutics Inc, Subsidiaries
  • Gene Biotherapeutics Inc - Locations And Subsidiaries

Summary Gene Biotherapeutics Inc(Gene Biotherapeutics) formerly known as Taxus Cardium Pharmaceuticals Group Inc, is a development stage company with focus on regenerative medicine.It develops manufacturing process and technology platforms for cardiovascular disease, wound healing and tissue engineering based on its core...

  • Biotherapeutic
  • United States
  • M&A
  • Product Initiative
  • BioTherapeutics Inc.
  • Northwest Biotherapeutics Inc, Subsidiaries
  • Northwest Biotherapeutics Inc, Subsidiaries

Summary Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company.It discovers and develops immunotherapy products to treat cancer in an effective way without toxicities associated with the normal chemotherapy drugs. The company by utilizing its proprietary technology platform, DCVax, developed...

  • Biological Therapy
  • Biotherapeutic
  • United States
  • Corporate Finance
  • Northwest Biotherapeutics, Inc.
  • Atara Biotherapeutics Inc, Subsidiaries
  • Atara Biotherapeutics Inc - Locations And Subsidiaries

Summary Atara Biotherapeutics Inc (Atara) is a biopharmaceutical company that develops T-cell based immunotherapies for the treatment of cancers, other autoimmune diseases, and severe viral infections.The company is evaluating its lead candidate tabelecleucel, formerly ATA129, in Phase 3 for the treatment of epstein-barr...

  • Biotherapeutic
  • Therapy
  • United States
  • Company
  • Atara Biotherapeutics, Inc.
  • Biotherapeutics Inc
  • Iovance Biotherapeutics Inc, Subsidiaries

Summary Iovance Biotherapeutics Inc (Iovance), formerly Lion Biotechnologies Inc is a biotechnology company that focuses on developing novel cancer immunotherapy products for treating various cancers. It develops products based on tumor-infiltrating lymphocyte (TIL) technology. The company’s lead product candidate,...

  • Biotechnology
  • Biotherapeutic
  • Healthcare
  • United States
  • BioTherapeutics Inc.
  • Northwest Biotherapeutics Inc, Subsidiaries
  • Northwest Biotherapeutics Inc, Subsidiaries

Summary Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer in an effective way without toxicities associated with the normal chemotherapy drugs. The company by utilizing its proprietary technology platform, DCVax,...

  • Biological Therapy
  • Biotherapeutic
  • United States
  • Corporate Finance
  • Northwest Biotherapeutics, Inc.
  • Sillajen Biotherapeutics, Key Employees
  • Sillajen Biotherapeutics, Subsidiaries

Summary Sillajen Biotherapeutics (SillaJen), formerly SillaJen Inc is a biotechnology company that designs and develops oncolytic immunotherapeutics for the treatment of cancer.The company’s pipeline product includes Pexa-Vec, an oncolytic immunotherapeutic virus which is in Phase III trial that is used for the treatment...

  • Biotherapeutic
  • Cancer
  • South Korea
  • M&A
  • BioTherapeutics Inc.
  • Profitability Analysis: Asterias Biotherapeutics Inc
  • SALES ANALYSIS: Asterias Biotherapeutics Inc

A textual analysis of the financial results for Asterias Biotherapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including...

  • Biological Therapy
  • Biotherapeutic
  • United States
  • Company Financials
  • Asterias Biotherapeutics, Inc.
  • Leverage Analysis: Northwest Biotherapeutics, Inc.
  • PRICE ANALYSIS: Northwest Biotherapeutics, Inc.

A textual analysis of the financial results for Northwest Biotherapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including...

  • Biological Therapy
  • Biotherapeutic
  • United States
  • Company Financials
  • Northwest Biotherapeutics, Inc.
  • Valuation multiples (Northwest Biotherapeutics, Inc.)
  • Share price (Northwest Biotherapeutics, Inc.)

Northwest Biotherapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s Northwest Biotherapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions...

  • Biological Therapy
  • Biotherapeutic
  • United States
  • Corporate Finance
  • Northwest Biotherapeutics, Inc.
  • INTEGRATED BIOTHERAPEUTICS, INC. OVERVIEW
  • INTEGRATED BIOTHERAPEUTICS, INC. SNAPSHOT

Integrated BioTherapeutics, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Integrated BioTherapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the Integrated BioTherapeutics, Inc.’s pharmaceutical research and development focus. The report provides comprehensive...

  • Biotherapeutic
  • Infectious Disease
  • United States
  • Company Operations
  • BioTherapeutics Inc.
  • INTEGRATED BIOTHERAPEUTICS INC, KEY COMPETITORS
  • INTEGRATED BIOTHERAPEUTICS INC - KEY COMPETITORS

Summary Integrated BioTherapeutics Inc (IBT) is a biotechnology company that discovers novel vaccines and therapeutics for infectious diseases.The company’s products include polyclonal and monoclonal antibodies raised against various emerging pathogens, vaccines and therapeutics against bacteria, pan-filovirus antibody...

  • Biotherapeutic
  • Pharmaceutical
  • United States
  • Deals & Alliance
  • BioTherapeutics Inc.
  • Igenica Biotherapeutics Inc, Key Competitors
  • Igenica Biotherapeutics Inc - Key Employees

Summary Igenica Biotherapeutics Inc (Igenica) is a provider of antibody drug conjugate services.The company’s product candidates includes IGN523, a humanized monoclonal antibody used to multiple hematologic and solid tumors. It offers IGN786, which is used novel target such as SAIL and IGN381, a novel approach to...

  • Biotherapeutic
  • Pharmaceutical
  • United States
  • Company
  • Igenica Biotherapeutics, Inc.
  • OXFORD BIOTHERAPEUTICS LTD - KEY COMPETITORS
  • OXFORD BIOTHERAPEUTICS LTD, KEY EMPLOYEES

Summary Oxford BioTherapeutics Ltd (Oxford BioTherapeutics) is a biotechnology company that develops antibody drug conjugates for the treatment of variety of cancers.The company provides OGAP technology is used to define the best targets for the development of ADCs. It also offers target and biomarker discovery and...

  • Biological Therapy
  • Biotherapeutic
  • Pharmaceutical
  • United States
  • Company
  • BRIGHTPATH BIOTHERAPEUTICS CO LTD - KEY COMPETITORS
  • BRIGHTPATH BIOTHERAPEUTICS CO LTD - LOCATIONS AND SUBSIDIARIES

Summary BrightPath Biotherapeutics Co Ltd (BrightPath Biotherapeutics) formerly known as GreenPeptide Co Ltd is a biopharmaceutical venture company that develops novel cancer immunotherapies.The company operates on drug discovery research and early clinical development of cancer immunotherapy; conducts early-phase clinical...

  • Biological Therapy
  • Biotherapeutic
  • Pharmaceutical
  • Japan
  • Deals & Alliance

Aeglea BioTherapeutics Inc (AGLE) - Financial and Strategic SWOT Analysis Review Section ## - About the Company Aeglea BioTherapeutics Inc - Key Information Aeglea BioTherapeutics Inc - Overview Aeglea BioTherapeutics Inc - Key Employees Aeglea

  • Biotherapeutic

Atara Biotherapeutics Inc (ATRA) - Financial and Strategic SWOT Analysis Review Section ## - About the Company Atara Biotherapeutics Inc - Key Information Atara Biotherapeutics Inc - Overview Atara Biotherapeutics Inc - Key Employees Atara

  • Biological Therapy
  • Biotherapeutic
  • Synergys Biotherapeutics Inc - Key Employees
  • Synergys Biotherapeutics Inc - Locations And Subsidiaries

Summary Synergys Biotherapeutics Inc (Synergys Biotherapeutics) is an antibody therapeutic company that develops multifunctional anti-vasculogenic and immuno-oncology antibody therapeutics. The company’s pipeline portfolio includes multifunctional anti-vasculogenic antibody fusion molecule for the treatment of triple negative...

  • Biological Therapy
  • Biotherapeutic
  • United States
  • Deals & Alliance
  • Synergys Biotherapeutics, Inc.
  • Alethia Biotherapeutics Inc, Key Employees
  • Alethia Biotherapeutics Inc - Key Competitors

Summary Alethia Biotherapeutics Inc (Alethia Biotherapeutics) is a biotechnology company that discovers and develops therapeutic products. The company’s products comprise AB-25E9 bone antiresorptive, AB-3A4 invasive carcinomas treatment products, and AB-16B5 EMT inhibitors. It also offers therapeutic pipeline products,...

  • Biotherapeutic
  • Canada
  • Deals & Alliance
  • Supply
  • Alethia Biotherapeutics Inc.

The company develops ITK-## for the treatment of hormone refractory prostate cancer.

  • Biotherapeutic

Northwest Biotherapeutics Inc (NWBO) - Financial and Strategic SWOT Analysis Review Table of Contents Table of Contents ## Section ## - About the Company ## Northwest Biotherapeutics Inc - Key Facts ## Northwest Biotherapeutics Inc - Key Employees ## Northwest

  • Biological Therapy
  • Biotherapeutic
  • Turkey
  • GTC Biotherapeutics targets and partners (2012 -YTD2016)
  • GTC Biotherapeutics partnership volume and value trend (2012-YTD2016)

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: Datamonitors' GTC Biotherapeutics,...

  • Biotherapeutic
  • United States
  • Company
  • Corporate Finance
  • GTC Biotherapeutics, Inc.
  • PROTALIX BIOTHERAPEUTICS, INC. SNAPSHOT
  • PROTALIX BIOTHERAPEUTICS, INC. OVERVIEW

Protalix BioTherapeutics, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Protalix BioTherapeutics, Inc. - Product Pipeline Review - 2015’, provides an overview of the Protalix BioTherapeutics, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information...

  • Biotherapeutic
  • World
  • Company Operations
  • Product Initiative
  • Protalix BioTherapeutics, Inc.